moraes daniel clemente (11 résultats)

Etat : New.

Etat : New.

Hardcover. Etat : new. Hardcover. Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Hardcover. Etat : new. Hardcover. Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Hardcover. Etat : new. Hardcover. Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Etat : New. Print on Demand.

Etat : New. PRINT ON DEMAND.

Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance.

Buch. Etat : Neu. Multidrug-Resistant Fungi | Buch | Englisch | 2026 | MDPI AG | EAN 9783725873463 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.